Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
-1.72%
)
Bitcoin
70,455.80
(
-0.09%
)
News Focus
News Focus

Replies to post #14408 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #14408 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

tony111

08/25/15 10:39 PM

#14416 RE: DewDiligence #14408

Dew,

Is formulation patent easy to be invalidated? I seem to have an impression that XR formulation patent strategy is quite successful in extending the patent life of the original drug.